skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Thrombus radioimmunoscintigraphy: an approach using monoclonal antiplatelet antibody

Journal Article · · Proc. Natl. Acad. Sci. U.S.A.; (United States)

An approach to thrombus imaging using a monoclonal antiplatelet antibody labeled with In or STI is described. The antibody (7E3) prepared against human platelets inhibits the interaction between fibrinogen-coated beads and both human and dog platelets. 7E3 is an IgG1 that binds to the complexed glycoprotein IIb/IIIa. Ninety percent of a tracer dose of radiolabeled 7E3 binds to human platelets and 50% binds to dog platelets. In vitro studies showed that virtually all of the platelet-bound radioactivity becomes incorporated into clots formed by adding thrombin to whole blood. 7E3 was labeled with In by the cyclic anhydride diethylenetriaminepentaacetic acid method or by radioiodination with STI. With el camera, visualization of venous and arterial thrombi as well as sites of initial injury without visible thrombi, could be observed 1-1.5 hr after injection. There was no need for delayed imaging because of the fast clearance of radioactivity from the circulation nor was there need for blood pool subtraction. Two to 10-hr thrombi could be imaged but 48-hr thrombi were not detectable with this method. No change in platelet counts before and after the injection of labeled 7E3 nor increased bleeding tendency occurred. The advantages of this method are a shorter preimaging preparation time, faster visualization after injection, and no need for delayed imaging or subtraction techniques. For these reasons human investigations seem to be warranted.

Research Organization:
State Univ. of New York (SUNY), Stony Brook, NY (United States)
DOE Contract Number:
AC02-76CH00016
OSTI ID:
6289533
Journal Information:
Proc. Natl. Acad. Sci. U.S.A.; (United States), Vol. 82:10
Country of Publication:
United States
Language:
English